- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA signature in liver cancer
Authors
Keywords
miRNA, Liver cancer, Hepatocellular carcinoma
Journal
PATHOLOGY RESEARCH AND PRACTICE
Volume 219, Issue -, Pages 153369
Publisher
Elsevier BV
Online
2021-02-09
DOI
10.1016/j.prp.2021.153369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma
- (2020) Asahiro Morishita et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- MicroRNAs, DNA damage response and ageing
- (2020) Maryam Majidinia et al. BIOGERONTOLOGY
- Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3
- (2020) Xiaojie Li et al. BMC Medical Genetics
- Investigation of the Association of miRNA-499, miRNA-146a, miRNA-196a2 Loci with Hepatocellular Carcinoma Risk: A Case–Control Study Involving 1507 Subjects
- (2020) Sheng Zhang et al. DNA AND CELL BIOLOGY
- MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
- (2020) Guohua Lou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-455 Inhibits HepG2 Cell Proliferation and Promotes Apoptosis by Targeting RhoC
- (2020) S. L. Xie et al. MOLECULAR BIOLOGY
- MicroRNA-294 promotes cell proliferation, migration, and invasion in SMMC-7721 hepatoma carcinoma cells by activating the JNK/ERK signaling pathway
- (2020) Xianping Cheng et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus–related hepatocellular carcinoma
- (2020) Pornpitra Pratedrat et al. PLoS One
- Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma
- (2020) Aya O. Bashir et al. LIFE SCIENCES
- Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p
- (2020) Xiang Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- ZEB1 mediates doxorubicin (Dox) resistance and mesenchymal characteristics of hepatocarcinoma cells
- (2019) Lin Long et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression
- (2019) Weiqing Qu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
- (2019) Yingjun Xie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689
- (2019) Hui Zeng et al. Drug Design Development and Therapy
- miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma
- (2019) Kamesh R. Babu et al. Scientific Reports
- miR-501 acts as an independent prognostic factor that promotes the epithelial–mesenchymal transition through targeting JDP2 in hepatocellular carcinoma
- (2019) Weixuan Yu et al. Human Cell
- Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma
- (2019) Hao Zhuang et al. Cell Death & Disease
- Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma
- (2019) Bin Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2
- (2019) Chaoyong Tu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The coordination between ZNF217 and LSD1 contributes to hepatocellular carcinoma progress and is negatively regulated by miR-101
- (2019) Wenzhe Si et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway
- (2019) Hui Tang et al. DIGESTIVE AND LIVER DISEASE
- HBV ‐regulated growth of liver cancer cells occurs through the miR‐340‐5p‐ ATF 7‐ HSPA 1B axis
- (2019) Feifei Song et al. CANCER SCIENCE
- Epigenetic Regulation of UDP-Glucuronosyltransferase by microRNA-200a/-183: Implications for Responses to Sorafenib Treatment in Patients with Hepatocellular Carcinoma
- (2019) Yang Ge et al. CANCER LETTERS
- miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis
- (2019) Lianshu Piao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1
- (2019) Yuhui Yu et al. Biochemistry and Cell Biology
- MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133+ hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway
- (2019) Yunxiuxiu Xu et al. Aging-US
- Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma
- (2019) Lina Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway
- (2019) Rong-Zheng Ran et al. EXPERIMENTAL CELL RESEARCH
- mirRNA-365b promotes hepatocellular carcinoma cell migration and invasion by downregulating SGTB
- (2019) Qi Tian et al. Future Oncology
- miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19
- (2019) Xiaobin Yao et al. GENE
- Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell
- (2019) Xu Hou et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2
- (2019) Ying Zan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs
- (2019) Xiaochen Gai et al. Journal of Genetics and Genomics
- MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29
- (2019) Huimin Du et al. LIFE SCIENCES
- Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis
- (2019) Hua-yu Wu et al. PATHOLOGY RESEARCH AND PRACTICE
- miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8
- (2019) Tao Yin et al. PATHOLOGY RESEARCH AND PRACTICE
- Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value
- (2019) Yao Cui et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2
- (2019) Weihua Ren et al. Cell Death & Disease
- miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1
- (2019) Jian Pu et al. Human Gene Therapy Clinical Development
- miR‐584‐5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2
- (2019) Huamei Wei et al. Molecular Genetics & Genomic Medicine
- Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma
- (2019) Jian Wu et al. Aging-US
- miR-629–5p promotes growth and metastasis of hepatocellular carcinoma by activating β-catenin
- (2019) Xin Tao et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4
- (2019) Yang Guo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma
- (2019) Zide Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Upregulation of microRNA‐140‐3p inhibits epithelial‐mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN
- (2019) Qiu‐Yin Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A miR‐194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma
- (2019) Hoin Kang et al. JOURNAL OF PATHOLOGY
- Adipose-derived exosomes deliver miR-23a/b to regulate tumor growth in hepatocellular cancer by targeting the VHL/HIF axis
- (2019) Yang Liu et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2
- (2019) Wen-Tao Zhao et al. LABORATORY INVESTIGATION
- MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Axis
- (2019) Huili Wang et al. PHARMACOLOGY
- MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
- (2019) Shun-Zhen Zheng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells
- (2019) Luc Gailhouste et al. Cell Death & Disease
- Gold nano-particles (AuNPs) carrying miR-326 targets PDK1/AKT/c-myc axis in hepatocellular carcinoma
- (2019) Yichao Mo et al. Artificial Cells Nanomedicine and Biotechnology
- NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways
- (2019) Fanzheng Meng et al. EBioMedicine
- TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
- (2019) Chuanfei Li et al. Aging-US
- miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein
- (2019) Shuangjiang Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma
- (2019) Beilei Zhang et al. CANCER LETTERS
- The roles of microRNAs in epigenetic regulation
- (2019) Qian Yao et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG
- (2019) Shifeng Chen et al. DNA AND CELL BIOLOGY
- Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer
- (2019) You Yu et al. EXPERIMENTAL CELL RESEARCH
- Antitumor Effect of Pyrogallol via miR-134 Mediated S Phase Arrest and Inhibition of PI3K/AKT/Skp2/cMyc Signaling in Hepatocellular Carcinoma
- (2019) Hyojin Ahn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
- (2019) Meng-Xuan Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma
- (2019) Moamena S. El-Hamouly et al. MOLECULAR BIOLOGY REPORTS
- Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection
- (2019) Sung Kyu Song et al. PLoS One
- microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma
- (2019) Zhufeng Lu et al. Cell Death & Disease
- MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9
- (2019) Bowen Yao et al. Artificial Cells Nanomedicine and Biotechnology
- miR‐106b‐5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3
- (2019) Hao Gu et al. Cancer Medicine
- Micro RNA ‐9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA 2
- (2019) Xiangang Xu et al. FEBS Open Bio
- miR‐1249‐3p accelerates the malignancy phenotype of hepatocellular carcinoma by directly targeting HNRNPK
- (2019) Hongchun Shu et al. Molecular Genetics & Genomic Medicine
- Dysregulation of the miR-325–3p/DPAGT1 axis supports HBV-positive HCC chemoresistance
- (2019) Rui Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3
- (2019) Liang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP
- (2019) Yao Xian et al. BIOMEDICINE & PHARMACOTHERAPY
- 125I suppressed the Warburg effect viaregulating miR-338/PFKL axis in hepatocellular carcinoma
- (2019) Jiaping Zheng et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-1181 supports the growth of hepatocellular carcinoma by repressing AXIN1
- (2019) Zewen Song et al. BIOMEDICINE & PHARMACOTHERAPY
- P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer via Wnt/β‐catenin signal pathway
- (2019) Jing Zhao et al. CANCER SCIENCE
- Targeted inhibition of MCT4 disrupts intracellular pH homeostasis and confers self-regulated apoptosis on hepatocellular carcinoma
- (2019) Youbo Zhao et al. EXPERIMENTAL CELL RESEARCH
- Myrothecine A modulates the proliferation of HCC cells and the maturation of dendritic cells through downregulating miR-221
- (2019) Yi Fu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway
- (2019) Maheshkumar Kannan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNAs in breast cancer: Roles, functions, and mechanism of actions
- (2019) Maryam Abolghasemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
- (2019) Lei Guan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Integrated analysis of hypoxia-induced miR-210 signature as a potential prognostic biomarker of hepatocellular carcinoma: a study based on The Cancer Genome Atlas
- (2019) Yi Dai et al. Journal of Zhejiang University-SCIENCE B
- miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1
- (2019) Meihua Wang et al. OncoTargets and Therapy
- MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
- (2019) Bin Yang et al. Cell Death & Disease
- miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
- (2019) Yue Zhou et al. Cell Death & Disease
- HIF-1-miR-219-SMC4 Regulatory Pathway Promoting Proliferation and Migration of HCC under Hypoxic Condition
- (2019) Yang Chen et al. Biomed Research International
- Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma
- (2019) Hao Zheng et al. Hormones & Cancer
- STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
- (2019) Carol Lee et al. Cancers
- Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
- (2019) Nannan Zhang et al. Molecular Genetics & Genomic Medicine
- MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis
- (2019) Mengyun Ke et al. BIOMEDICINE & PHARMACOTHERAPY
- Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells
- (2019) Peng Yuan et al. CANCER LETTERS
- MicroRNA‐493‐5p‐mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion
- (2019) Ken Yasukawa et al. CANCER SCIENCE
- MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL
- (2019) Jia He et al. Biomed Research International
- Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation
- (2019) Silvia Baldari et al. Cells
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer
- (2018) A Sanchez-Mejias et al. INTERNATIONAL JOURNAL OF CANCER
- Positive feedback loop of lncRNA LINC01296/miR-598/Twist1 promotes non-small cell lung cancer tumorigenesis
- (2018) Lijuan Xu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miR-365 Regulates Liver Cancer Stem Cells via RAC1 pathway
- (2018) Ze-Bin Jiang et al. MOLECULAR CARCINOGENESIS
- Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway
- (2018) Changwei Dou et al. ONCOGENE
- MicroRNA-146a-5p Enhances Radiosensitivity in Hepatocellular Carcinoma through Replication Protein A3 Induced Activation of the DNA Repair Pathway
- (2018) Jing Luo et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT
- (2018) Yufeng Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features
- (2018) Yuanzhuo Gu et al. CANCER RESEARCH
- MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma
- (2018) Wenjie Han et al. CELLULAR SIGNALLING
- 5-hydroxytryptamine receptor 1D aggravates hepatocellular carcinoma progression via FoxO6 in AKT-dependent and independent manners
- (2018) Xueliang Zuo et al. HEPATOLOGY
- MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma
- (2018) Jian-gang Bi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activation
- (2018) Jie Tao et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway
- (2018) Yibin Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3
- (2018) Shan Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma
- (2018) Qian Wei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis
- (2018) Yu Zhu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Influence of miR-520e-mediated MAPK signaling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2
- (2018) Jing-hui Tian et al. JOURNAL OF VIRAL HEPATITIS
- MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma
- (2018) Yingjie Shao et al. MOLECULAR THERAPY
- miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway
- (2018) Fei Cao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1
- (2018) Pei-Wei Yang et al. PHYTOMEDICINE
- MiR-490-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion by Directly Regulating ROBO1
- (2017) Weiqing Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Role of microRNAs in inflammation-associated liver cancer
- (2016) Huan Lin et al. Cancer Biology & Medicine
- TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial–mesenchymal transition and cancer stem cell phenotypes
- (2015) Fengchao Liu et al. CANCER LETTERS
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
- (2013) Longlong Bao et al. CANCER LETTERS
- Hepatitis C virus induced up-regulation of microRNA-27: A novel mechanism for hepatic steatosis
- (2013) Ragunath Singaravelu et al. HEPATOLOGY
- Genetics and epigenetics of liver cancer
- (2013) Cigdem Ozen et al. New Biotechnology
- Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation
- (2011) Zhong-Bo Han et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Role of MicroRNAs in Human Liver Cancers
- (2011) Chiara Braconi et al. SEMINARS IN ONCOLOGY
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype
- (2008) Erin Connolly et al. AMERICAN JOURNAL OF PATHOLOGY
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival
- (2008) J. Jiang et al. CLINICAL CANCER RESEARCH
- Identification of metastasis-related microRNAs in hepatocellular carcinoma
- (2008) Anuradha Budhu et al. HEPATOLOGY
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
- (2008) F Fornari et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More